SLC44A1

Chr 9AR

solute carrier family 44 member 1

Also known as: CD92, CDW92, CHTL1, CONATOC, CTL1

Enables choline transmembrane transporter activity and ethanolamine transmembrane transporter activity. Involved in choline transport; ethanolamine transport; and transmembrane transport. Located in several cellular components, including cytosol; mitochondrial outer membrane; and nucleoplasm. Implicated in high grade glioma. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.271 OMIM phenotype
Clinical SummarySLC44A1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 90 VUS of 135 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.27LOEUF
pLI 0.997
Z-score 4.81
OE 0.12 (0.060.27)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.73Z-score
OE missense 0.74 (0.670.82)
260 obs / 351.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.12 (0.060.27)
00.351.4
Missense OE?0.74 (0.670.82)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 4 / 34.5Missense obs/exp: 260 / 351.3Syn Z: 0.38

This gene — mechanism propensity

DN
0.4983th %ile
GOF
0.76top 25%
LOF
0.4627th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF83% of P/LP variants are LoF · LOEUF 0.27
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

135 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic1
VUS90
Likely Benign10
Benign8
Conflicting1
5
Pathogenic
1
Likely Pathogenic
90
VUS
10
Likely Benign
8
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
0
1
0
5
Likely Pathogenic
1
0
0
0
1
VUS
0
90
0
0
90
Likely Benign
0
3
0
7
10
Benign
0
2
4
2
8
Conflicting
1
Total59559115

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

37 pathogenic / likely-pathogenic (of 44) ClinVar copy-number / structural variants overlap SLC44A1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC44A1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →